Page last updated: 2024-10-24

mitochondrial small ribosomal subunit

Definition

Target type: cellularcomponent

The smaller of the two subunits of a mitochondrial ribosome. [GOC:mcc]

The mitochondrial small ribosomal subunit (mSSU) is a crucial component of the mitochondrial protein synthesis machinery. It is composed of a complex assembly of ribosomal RNAs (rRNAs) and proteins, collectively referred to as mS rRNA and mS proteins, respectively. The mSSU, along with the mitochondrial large ribosomal subunit (mLSU), forms the complete mitochondrial ribosome (mitoribosome) responsible for translating mitochondrial mRNAs into proteins.

The mSSU plays a critical role in initiating and carrying out protein synthesis within mitochondria. Its structure and function are highly specialized, reflecting the unique characteristics of mitochondrial translation.

**Structure of the mSSU:**

The mSSU is a highly organized structure consisting of:

* **mS rRNA:** The mSSU contains a single, highly structured rRNA molecule called mS rRNA. This rRNA molecule is responsible for providing the structural framework of the mSSU and contributes significantly to its functional properties.
* **mS Proteins:** Multiple proteins, designated as mS proteins, associate with the mS rRNA. These proteins are involved in various aspects of mSSU function, including:
* **Binding to mRNA:** mS proteins facilitate the binding of mRNA to the mSSU during translation initiation.
* **Ribosome assembly:** They contribute to the proper assembly and stability of the mSSU.
* **Catalytic activity:** Certain mS proteins may participate in catalytic reactions involved in the process of translation.

**Key Functions of the mSSU:**

* **mRNA Binding:** The mSSU binds to mRNA, ensuring the correct positioning of the mRNA within the ribosome for translation.
* **Initiation of Translation:** The mSSU, in collaboration with initiation factors, plays a critical role in initiating protein synthesis by recruiting the initiator tRNA and positioning it at the start codon of the mRNA.
* **Decoding:** The mSSU ensures the accurate decoding of mRNA codons into amino acids, maintaining the fidelity of protein synthesis.
* **Translocation:** The mSSU facilitates the movement of the mRNA and tRNA along the ribosome during translation elongation.

**Importance of the mSSU:**

The mSSU is essential for mitochondrial protein synthesis. Defects in mS rRNA or mS proteins can disrupt the function of the mSSU, leading to impaired mitochondrial translation and ultimately, mitochondrial dysfunction. This can contribute to a range of human diseases, including mitochondrial disorders, neurodegenerative diseases, and cancer.

**Comparative Aspects:**

The mSSU shares similarities with the small ribosomal subunit (SSU) found in the cytoplasm of eukaryotic cells. However, there are significant differences in their structure and function, reflecting the unique environment and requirements of mitochondrial translation.

**Research Focus:**

Ongoing research aims to understand the intricate structure and function of the mSSU in greater detail. This knowledge is crucial for developing strategies to combat mitochondrial diseases and optimize mitochondrial function for human health.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Aurora kinase A-interacting proteinA small ribosomal subunit protein mS38 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NWT8]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
vx680N-arylpiperazine
crizotinibcrizotinib : A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that has R configuration at the chiral centre. The active enantiomer, it acts as a kinase inhibitor and is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Crizotinib: A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amineantineoplastic agent;
biomarker;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor